11. Length of hospital stay: league table of posterior median pairwise RoM and 95% CrI (lower triangle), and pairwise probabilities that a treatment is better than another (upper triangle).

Typical antipsychotic	0.546	0.673	0.654	0.810	0.828	0.820
0.99 (0.70, 1.38)	Atypical antipsychotic	0.651	0.604	0.801	0.818	0.827
0.94 (0.60, 1.43)	0.95 (0.63, 1.42)	Statin	0.498	0.716	0.736	0.596
0.94 (0.60, 1.47)	0.95 (0.55, 1.67)	1.00 (0.55, 1.88)	Opioid	0.685	0.700	0.561
0.83 (0.46, 1.39)	0.84 (0.48, 1.38)	0.88 (0.49, 1.52)	0.88 (0.42, 1.73)	Alpha2 agonist	0.515	0.305
0.82 (0.46, 1.37)	0.83 (0.47, 1.36)	0.88 (0.49, 1.49)	0.87 (0.41, 1.70)	0.99 (0.51, 1.90)	CHE inhibitor	0.278
0.92 (0.65, 1.18)	0.93 (0.69, 1.16)	0.98 (0.69, 1.30)	0.97 (0.55, 1.60)	1.10 (0.69, 1.75)	1.11 (0.70, 1.77)	Placebo

CHE: cholinesterase.

Crl: credible interval.

RoM: ratio of means.

Treatments other than placebo are in the order of decreasing surface under the cumulative ranking curve (SUCRA) value from upper left to lower right. For each comparison, the lower/right‐most treatment is the reference treatment. For example, the RoM estimate of 0.92 (95% CrI 0.65 to 1.18) in the lower triangle suggests an 8% reduction in mean length of hospital stay with typical antipsychotics compared to placebo. The corresponding probability estimate in the upper triangle suggests a probability of 82% that typical antipsychotics are better than placebo for length of hospital stay.